TB skin test for patients with rheumatologic conditions
Part of Infections clinical trials.
This trial is testing a new type of skin test (called ESAT6/CFP10) to check for TB infection in people who have a rheumatologic disease and are about to start certain medications (b/tsDMARDs). The goal is to see if this skin test works well for these patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have been diagnosed with at least one rheumatologic disease (like rheumatoid arthritis, lupus, or other similar conditions).
- You are planning to start a type of medication called b/tsDMARDs (biologic or targeted synthetic disease-modifying antirheumatic drugs).
- You can communicate in English or Chinese.
- You do not have active tuberculosis (TB) and you are not currently being treated for TB or a latent TB infection.
- You do not have a serious mental illness that would prevent you from participating.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a simple blood test that looks for signs of tuberculosis before you have a bronchoscopy, a procedure that lets doctors look inside your lungs. The blood test may help doctors find tuberculosis faster and more easily.
This trial tests a new skin test (EEC) to see if it can accurately detect tuberculosis infection in people aged 3 and older. It compares the test's results in healthy people, people with TB, and people with other lung diseases to check how well it works.
This study looks at how the immune system reacts in people with tuberculosis (TB), their close contacts, people with other lung diseases, and healthy volunteers. It aims to find better ways to diagnose and manage TB.
This study is looking at how a simple blood test can help monitor tuberculosis (TB) treatment. It may help doctors know sooner if the treatment is working.
This study looks for people who have recently completed standard treatment for drug-sensitive TB. Researchers want to check if certain tests can predict long-term health outcomes after treatment.
This study tests rapid TB screening and lab-style diagnostic methods to see how well they find TB disease and TB that is resistant to rifampin (a key TB drug). It may help doctors diagnose TB faster and more accurately, especially in people at higher risk.
Hear when a new Tuberculosis (TB) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.